Clinical trial

Effect of a Transversus Abdominis Plane Block on Operative Wound Healing, Stress, and Immune Response After a Cesarean Delivery

Name
003-06/22-03/007
Description
The primary purpose of this study is to determine whether the addition of a TAP block to standard analgesia after the cesarean delivery will impact postoperative wound healing and attenuate postoperative stress and immune response. Random allocation of participants in 3 groups: group SA (standard analgesia), group L (TAP block with levobupivacaine), and group D (TAP block with levobupivacaine + dexmedetomidine). All participants will undergo elective cesarean section through Pfannestiel incision under spinal anesthesia. They will receive standard postoperative pain management with acetaminophen, nonsteroidal anti-inflammatory drugs, and tramadol. Groups L and D will additionally receive bilateral ultrasound-guided TAP block with 20 ml 0,25% levobupivacaine or with 20 ml 0,25% levobupivacaine with the addition of 0,5 μg/kg dexmedetomidine. TAP block will be performed in the theatre immediately after the cesarean delivery. Venous blood samples will be collected before the surgery and on the third postoperative day. Complete blood count and serum cortisol levels will be measured. REEDA scale will be used for assessing wound healing.
Trial arms
Trial start
2024-04-01
Estimated PCD
2025-04-01
Trial end
2025-04-01
Status
Not yet recruiting
Treatment
Postoperative pain management with acetaminophen
During the 24 hours postoperatively, participants will receive 1 g acetaminophen intravenously (i.v.) three times a day. On the second and third postoperative days, participants will receive 1g acetaminophen per os three times a day.
Arms:
Group D, Group L, Group SA
Bilateral TAP Block with levobupivacaine
Ultrasound-guided bilateral TAP block will be performed, and 20 ml of 0,25 % levobupivacaine will be administered to the participant on each side.
Arms:
Group L
Bilateral TAP Block with levobupivacaine and dexmedetomidine
Ultrasound-guided bilateral TAP block will be performed, and 20 ml of 0,25 % levobupivacaine with the addition of 0,5 μg/kg dexmedetomidine will be administered to the participant on each side.
Arms:
Group D
Postoperative pain management with tramadol
During the 24 hours postoperatively, participants will receive 500 mg tramadol + 500 ml 0,9% NaCl i.v. continuously 30ml/h.
Arms:
Group D, Group L, Group SA
Postoperative pain management with ketoprofen
During the 24 hours postoperatively, participants will receive 100 mg ketoprofen + 100 ml of 0,9% NaCl i.v. twice a day. The first dose will be administered in the theatre at the end of the surgical procedure.
Arms:
Group D, Group L, Group SA
Postoperative pain management with ibuprofen
On the second and third postoperative days, participants will receive 600 mg ibuprofen per os three times a day.
Arms:
Group D, Group L, Group SA
Size
120
Primary endpoint
Wound healing
72 hours after the surgery
Measure the stress response (serum cortisol)
up to 72 hours
Measure immune response (neutrophil to lymphocyte ratio)
up to 72 hours
Measure immune response (platelet to lymphocyte ratio)
up to 72 hours
Eligibility criteria
Inclusion Criteria: * Patients scheduled for the elective cesarean section through Pfannenstiel incision under spinal anesthesia * Age \>18 * American Society of Anesthesiologists (ASA) physical status II * Body mass index \< 40 mg/kg² * \>35 gestational weeks Exclusion Criteria: * participant's refusal to participate in the study * ASA physical status \>II * emergency cesarean section * twin or triplets pregnancy * history of allergy to the local anesthetic or any other drug used in this study (dexmedetomidine, acetaminophen, tramadol, nonsteroidal anti-inflammatory drugs) * contraindications for spinal anesthesia or TAP block Drop out from the study: * the change in anesthetic technique from spinal to the general anesthesia * the need for the blood transfusion * acute mastitis, puerperal endometritis, and/or wound infection developed in the first 72 hours postoperatively * failed TAP block
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Prospective single-blind randomized control trial', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': "Participants will be randomly allocated to either a group SA receiving the standard postoperative analgesia or groups receiving the TAP block with levobupivacaine (group L) or levobupivacaine with the addition of dexmedetomidine (group D). The allocation sequence will be generated by a random number table. After signing an informed consent, participants and an anesthesiologist performing the TAP block will be informed about patients' group allocation. An independent observer, who will not know which group the participant belongs to, will assess wound healing using the standardized REEDA scale 72 hours after the cesarean delivery. The same independent observer will assess every participant at 4, 8, 12, 18, 24, and 72 hours after surgery for pain by using the pain numerical rating scale.", 'whoMasked': ['OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 120, 'type': 'ESTIMATED'}}
Updated at
2023-05-03

1 organization

4 products

3 indications

Indication
c-section
Indication
Wound Healing
Product
Tramadol
Product
Ketoprofen
Product
Ibuprofen